| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.47 | 0.02 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.3 | 0.02 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.02 |